Acromegaly caused by secretion of growth hormone by a non-Hodgkin's lymphoma.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  New England Journal of Medicine

• Publication date

  2000-06-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM200006223422504PMID 10861322
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of growth hormone-releasing hormone (GHRH) messenger ribonucleic acid and the presence of biologically active GHRH in human breast, endometrial, and ovarian cancers.

  1999cited by this paper
• The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997.

  1999cited by this paper
• World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

  1999cited by this paper
• Growth hormone: a paracrine growth factor in embryonic development?

  1998cited by this paper
• The somatogenic hormones and insulin-like growth factor-1: stimulators of lymphopoiesis and immune function.

  1997cited by this paper
• A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein.

  1997cited by this paper
• Endocrine/metabolic syndromes of cancer.

  1997cited by this paper
• Immunofunctional assay of human growth hormone (hGH) in serum: a possible consensus for quantitative hGH measurement.

  1996cited by this paper
• The effects of growth hormone and insulin-like growth factor I on the immune system of aged female monkeys.

  1996cited by this paper
• Localization of growth hormone messenger ribonucleic acid in the human immune system--a Clinical Research Center study.

  1996cited by this paper
• [A case of human growth hormone (h-GH)-producing adenocarcinoma of the lung].

  1995cited by this paper
• Effects of growth hormone and insulin-like growth factor I on the immune system.

  1995cited by this paper
• Clinical review 75: Recent advances in pathogenesis, diagnosis, and management of acromegaly.

  1995cited by this paper
• Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy.

  1995cited by this paper
• Spontaneous growth hormone (GH) secretion by unstimulated human lymphocytes and the effects of GH-releasing hormone and somatostatin.

  1994cited by this paper
• Acromegaly: Clinical and Biochemical Features in 500 Patients

  1994cited by this paper
• Recurrent acromegaly resulting from ectopic growth hormone gene expression by a metastatic pancreatic tumor

  1993cited by this paper
• Growth hormone secretion by human peripheral blood mononuclear cells detected by an enzyme-linked immunoplaque assay.

  1993cited by this paper
• Clinical manifestations of acromegaly.

  1992cited by this paper
• 111In-octreotide scintigraphy in oncology.

  1992cited by this paper
• Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells.

  1992cited by this paper
• Pituitary epithelial cell implants reverse the accumulation of CD4-CD8- lymphocytes in thymus glands of aged rats.

  1992cited by this paper
• Detection of Growth Hormone and Growth Hormone-Releasing Hormone-Related Messenger RNA in Rat Leukocytes by the Polymerase Chain Reaction

  1991cited by this paper
• Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins.

  1991cited by this paper
• Presence of growth hormone-releasing hormone-like immunoreactivity in human tumors: characterization of immunological and biological properties.

  1990cited by this paper
• Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations.

  1988cited by this paper
• Production of immunoreactive growth hormone by mononuclear leukocytes

  1988cited by this paper
• Growth hormone receptor and serum binding protein: purification, cloning and expression

  1987cited by this paper
• GH3 pituitary adenoma cells can reverse thymic aging in rats.

  1986cited by this paper
• Specific growth hormone receptors on human peripheral mononuclear cells: reexpression, identification, and characterization.

  1985cited by this paper
• Acromegaly due to secretion of growth hormone by an ectopic pancreatic islet-cell tumor.

  1985cited by this paper
• Acromegaly and Cushing's syndrome associated with a foregut carcinoid tumor.

  1981cited by this paper
• Ectopic human growth hormone in ovaries and breast cancer.

  1979cited by this paper
• Bronchial carcinoid tumour with acromegaly in two patients.

  1974cited by this paper
• Synthesis and release of human growth hormone from lung carcinoma in cell culture.

  1972cited by this paper
• Ectopic growth hormone syndrome associated with lung cancer.

  1971cited by this paper
• On the presence of immunoreactive growth hormone in a bronchogenic carcinoma.

  1969cited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Cirrhotic Liver Expresses Low Levels of the Full-Length and Truncated Growth Hormone Receptors*

  year unknowncited by this paper

• Ectopic Acromegaly Caused by Peripheral Ectopic Growth Hormone Hypersecretion: A Case Report and Literature Review

  2025cites this paper
• Ectopic GHRH production: revisiting a rare cause of acromegaly

  2025cites this paper
• The clinical and biochemical spectrum of ectopic acromegaly.

  2024cites this paper
• "Micromegaly": Acromegaly with apparently normal GH, an entity on its own?

  2024cites this paper
• Эктопическая акромегалия вследствие нейроэндокринных опухолей легких: первое описание в России трех клинических случаев

  2024cites this paper
• Growth hormone and gastrointestinal malignancy: An intriguing link

  2023cites this paper
• 7 Natural History and Management Options of Acromegaly acromegaly

  2022cites this paper
• Growth Hormone Excess: Implications and Management.

  2022cites this paper
• Acromegaly Caused by Ectopic Growth Hormone Releasing Hormone Secretion: A Review

  2022cites this paper
• Biochemical discrepancies in the evaluation of the somatotroph axis: Elevated GH or IGF-1 levels do not always diagnose acromegaly.

  2022cites this paper
• Prevalence, incidence, and risk of cancers in patients with acromegaly: review

  2022cites this paper
• Diagnosis and Treatment of Acromegaly: An Update.

  2022cites this paper
• GHRH-producing tumors and other neuroendocrine neoplasms associated with acromegaly and/or gigantism

  2021cites this paper
• Treatment of NET-Related Symptoms

  2021cites this paper
• Paraneoplastic autoimmune hypophysitis: An emerging concept.

  2021cites this paper
• Pathology of pituitary growth hormone excess

  2021cites this paper
• Ectopic Acromegaly Secondary to Bronchial Tumour: A Case Report of Rare Occurrence

  2021influential citation
• Anterior Pituitary

  2020cites this paper
• Epidemiology of Functioning Pituitary Adenomas

  2020cites this paper
• The spectrum of lymphoproliferative disorders in endocrine organs: from histology to molecular genetics

  2019cites this paper
• The Clinicopathological Spectrum of Acromegaly

  2019cites this paper
• Physiologic and Pathophysiologic Alterations of the Neuroendocrine Components of the Reproductive Axis

  2019cites this paper
• Paraneoplastic syndromes and other systemic disorders associated with neuroendocrine neoplasms.

  2019cites this paper
• Growth hormone-producing pituitary adenomas in childhood and young adulthood: clinical features and outcomes

  2018cites this paper
• Primary pituitary diffuse large B-cell lymphoma with somatotroph hyperplasia and acromegaly: case report.

  2017cites this paper
• Targeting oncogenic receptor : From molecular physiology to currently the standard of target therapy

  2017cites this paper
• Co-Occurrence of Acromegaly and Hematological Disorders: A Myth or Common Pathogenic Mechanism

  2017cites this paper
• Targeting oncogenic receptor, currently the standard of care

  2017cites this paper
• Pituitary Gland Disorders

  2017cites this paper
• Diagnostic challenges and management of a patient with acromegaly due to ectopic growth hormone-releasing hormone secretion from a bronchial carcinoid tumour

  2017cites this paper
• Endoscopic Endonasal versus Microsurgical Transsphenoidal Approach for Growth Hormone-Secreting Pituitary Adenomas-Systematic Review and Meta-Analysis.

  2017cites this paper
• Acromegaly: clinical features at diagnosis

  2017cites this paper
• Ectopic Acromegaly Arising from a Pituitary Adenoma within the Bony Intersphenoid Septum of a Patient with Empty Sella Syndrome

  2016cites this paper
• Acromegaly in a patient with a pulmonary neuroendocrine tumor: case report and review of current literature

  2016cites this paper
• Pasireotide: a novel treatment for patients with acromegaly

  2016cites this paper
• Downregulating oncogenic receptor: From bench to clinic

  2016cites this paper
• Diagnóstico y tratamiento actual de la acromegalia

  2015cites this paper
• [Current diagnosis and treatment of acromegaly].

  2015cites this paper
• Pancreatic Neuroendocrine Tumors Producing GHRH, GH, Ghrelin, PTH, or PTHrP

  2015cites this paper
• Ectopic acromegaly due to a growth hormone-secreting neuroendocrine-differentiated tumor developed from ovarian mature cystic teratoma

  2015cites this paper
• The quality of life and psychological, social and cognitive functioning of patients with acromegaly.

  2015cites this paper
• Diagnosis, treatment and clinical perspectives of acromegaly

  2015cites this paper
• Capítulo 8 – Tratamiento de la acromegalia: presente y futuro

  2015cites this paper
• Ectopic prolactin secretion from a perivascular epithelioid cell tumor (PEComa).

  2014cites this paper
• Chapter 21 – Physiological and Pathophysiological Alterations of the Neuroendocrine Components of the Reproductive Axis

  2014cites this paper
• Acromegaly.

  2014cites this paper
• Ectopic acromegaly due to a GH-secreting pituitary adenoma in the sphenoid sinus: a case report and review of the literature

  2013cites this paper
• Ectopic Hypothalamic and Pituitary Hormone Secreting Syndromes

  2013cites this paper
• Ectopic acromegaly due to growth hormone releasing hormone

  2013cites this paper
• Acromegaly due to an ectopic pituitary adenoma in the clivus: case report and review of literature

  2012cites this paper
• The Coexistence of an Intrasellar Adenoma, Lymphocytic Hypophysitis, and Primary Pituitary Lymphoma in a Patient with Acromegaly

  2011cites this paper
• Chapter 14 – Acromegaly

  2011cites this paper
• CHAPTER 9 – Pituitary Masses and Tumors

  2011cites this paper
• Chapter 9 – The Hypothalamus

  2011cites this paper
• KAPITEL 5 – Akromegalie

  2010cites this paper
• Paraneoplastic syndromes secondary to neuroendocrine tumours.

  2010cites this paper
• Systematic Approach to Radiology of Endocrine Disorders Affecting the Musculoskeletal System

  2009cites this paper
• AME P OSITION S TATEMENT ON CLINICAL MANA g EMENT O f ACROME g AL y

  2009cites this paper
• 96 – Diseases of Hypothalamic Origin

  2009cites this paper
• AME POSITION STATEMENT ON CLINICAL MANAgEMENT Of ACROMEgALy

  2009cites this paper
• Acromegaly

  2008cites this paper
• Acromegaly Secondary to Growth Hormone-releasing Hormone Secreted by an Incidentally Discovered Pheochromocytoma

  2007cites this paper
• Medical progress: Acromegaly.

  2006cites this paper
• Therapeutisches Management bei der Akromegalie

  2006cites this paper
• Acromegaly, Day One and Now, 120 Years Later

  2006cites this paper
• [Therapeutic management of acromegaly].

  2006cites this paper
• [Five year remission of GHRH secreting bronchial neuroendocrine tumor with symptoms of acromegaly. Utility of chromogranin A in the monitoring of the disease].

  2006cites this paper
• Etiologic aspects and management of acromegaly.

  2005cites this paper
• PREVALÊNCIA DA APNÉIA DO SONO EM PACIENTES COM ACROMEGALIA E ANÁLISE DOS PARÂMETROS CEFALOMÉTRICOS À RESSONÂNCIA MAGNÉTICA

  2005cites this paper
• [Pancreatic endocrine tumor secreting growth hormone].

  2005cites this paper
• Tumeur endocrine pancréatique sécrétant l’hormone de croissance (GH)

  2005cites this paper
• Síndromes hormonales paraneoplásicos Paraneoplastic hormonal syndromes

  2005cites this paper
• [Paraneoplastic hormonal syndromes].

  2005cites this paper
• Síndromes hormonales paraneoplásicos

  2005cites this paper
• atualização Etiologic Aspects and Management of Acromegaly

  2005cites this paper
• Endocrine Changes in Critical Illness

  2004cites this paper
• Paraneoplastic endocrine syndromes: A review

  2003cites this paper
• Problems with GH doping in sports

  2003cites this paper
• Interaction between the hypothalamo-pituitary-adrenal axis and the immunological system

  2003cites this paper
• Acromegaly: disease or syndrome? Not only a semantic question

  2003cites this paper
• Acromegaly due to ectopic secretion of GHRH by bronchial carcinoid in a patient with empty sella

  2003cites this paper
• [A 46-year-old woman with clinical characteristics of growth hormone excess].

  2002cites this paper
• Growth hormone can act as a cytokine controlling survival and proliferation of immune cells: new insights into signaling pathways.

  2002cites this paper
• The tall, rapidly growing infant, child, and adolescent

  2001cites this paper
• CD markers in pituitary adenomas

  2001cites this paper
• Effect of acute pharmacological modulation of plasma free fatty acids on GH secretion in acromegalic patients

  2001cites this paper
• Myeloid leukemic cells express and secrete bioactive pituitary-sized 23 kDa prolactin.

  2000cites this paper